BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 10814579)

  • 1. Provirus Mutations of Human T-Lymphotropic Virus 1 and 2 (HTLV-1 and HTLV-2) in HIV-1-Coinfected Individuals.
    Campos KR; Caterino-de-Araujo A
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32999083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of a novel and highly divergent HTLV-3 in a primate hunter in Cameroon.
    Zheng H; Wolfe ND; Sintasath DM; Tamoufe U; Lebreton M; Djoko CF; Diffo Jle D; Pike BL; Heneine W; Switzer WM
    Virology; 2010 Jun; 401(2):137-45. PubMed ID: 20353873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators.
    Forlani G; Abdallah R; Accolla RS; Tosi G
    Front Microbiol; 2013; 4():234. PubMed ID: 23986750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term prevalence follow-up (1967-2022) of HTLV-2 among vulnerable indigenous populations in the Amazon region of Brazil.
    Ishak R; de Oliveira GuimarĂ£es Ishak M; Abreu IN; Machado LFA; Lima SS; Queiroz MAF; Cayres-Vallinoto IM; Guerreiro JF; Vallinoto ACR
    Front Microbiol; 2023; 14():1217134. PubMed ID: 37425995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Epidemiological Impact of STIs among General and Vulnerable Populations of the Amazon Region of Brazil: 30 years of Surveillance.
    Machado LFA; Fonseca RRS; Queiroz MAF; Oliveira-Filho AB; Cayres-Vallinoto IMV; Vallinoto ACR; Ishak MOG; Ishak R
    Viruses; 2021 May; 13(5):. PubMed ID: 34067165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of Cell Death in Growing Human T-Cells and Cell Survival in Resting Cells in Response to the Human T-Cell Leukemia Virus Type 1 Tax.
    Mizuguchi M; Sasaki Y; Hara T; Higuchi M; Tanaka Y; Funato N; Tanaka N; Fujii M; Nakamura M
    PLoS One; 2016; 11(2):e0148217. PubMed ID: 26829041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T-cell leukemia virus type 1 (HTLV-1) Tax1 oncoprotein but not HTLV-2 Tax2 induces the expression of OX40 ligand by interacting with p52/p100 and RelB.
    Motai Y; Takahashi M; Takachi T; Higuchi M; Hara T; Mizuguchi M; Aoyagi Y; Terai S; Tanaka Y; Fujii M
    Virus Genes; 2016 Feb; 52(1):4-13. PubMed ID: 26739459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human T cell leukemia virus type 2 (HTLV-2) Tax2 has a dominant activity over HTLV-1 Tax1 to immortalize human CD4+ T cells.
    Imai M; Higuchi M; Kawamura H; Yoshita M; Takahashi M; Oie M; Matsuki H; Tanaka Y; Aoyagi Y; Fujii M
    Virus Genes; 2013 Feb; 46(1):39-46. PubMed ID: 23054433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular localization and cellular factors interaction of HTLV-1 and HTLV-2 Tax proteins: similarities and functional differences.
    Bertazzoni U; Turci M; Avesani F; Di Gennaro G; Bidoia C; Romanelli MG
    Viruses; 2011 May; 3(5):541-560. PubMed ID: 21994745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional activation of the interleukin-21 gene and its receptor gene by human T-cell leukemia virus type 1 Tax in human T-cells.
    Mizuguchi M; Asao H; Hara T; Higuchi M; Fujii M; Nakamura M
    J Biol Chem; 2009 Sep; 284(38):25501-11. PubMed ID: 19617351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human T-cell leukemia virus type 2 Tax protein induces interleukin 2-independent growth in a T-cell line.
    Kondo R; Higuchi M; Takahashi M; Oie M; Tanaka Y; Gejyo F; Fujii M
    Retrovirology; 2006 Dec; 3():88. PubMed ID: 17140451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tax & rex: overlapping genes of the Deltaretrovirus group.
    McGirr KM; Buehuring GC
    Virus Genes; 2006 Jun; 32(3):229-39. PubMed ID: 16732475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant activation of the interleukin-2 autocrine loop through the nuclear factor of activated T cells by nonleukemogenic human T-cell leukemia virus type 2 but not by leukemogenic type 1 virus.
    Niinuma A; Higuchi M; Takahashi M; Oie M; Tanaka Y; Gejyo F; Tanaka N; Sugamura K; Xie L; Green PL; Fujii M
    J Virol; 2005 Sep; 79(18):11925-34. PubMed ID: 16140768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDZ domain-binding motif of human T-cell leukemia virus type 1 Tax oncoprotein is essential for the interleukin 2 independent growth induction of a T-cell line.
    Tsubata C; Higuchi M; Takahashi M; Oie M; Tanaka Y; Gejyo F; Fujii M
    Retrovirology; 2005 Jul; 2():46. PubMed ID: 16042787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T-cell leukemia virus type 2 (HTLV-2) Tax protein transforms a rat fibroblast cell line but less efficiently than HTLV-1 Tax.
    Endo K; Hirata A; Iwai K; Sakurai M; Fukushi M; Oie M; Higuchi M; Hall WW; Gejyo F; Fujii M
    J Virol; 2002 Mar; 76(6):2648-53. PubMed ID: 11861831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation, cloning, and complete nucleotide sequence of a phenotypically distinct Brazilian isolate of human T-lymphotropic virus type II (HTLV-II).
    Lewis MJ; Novoa P; Ishak R; Ishak M; Salemi M; Vandamme AM; Kaplan MH; Hall WW
    Virology; 2000 May; 271(1):142-54. PubMed ID: 10814579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of CREB- and NF-kappaB-mediated transactivation by human T lymphotropic virus type II (HTLV-II) and type I (HTLV-I) tax proteins.
    Lewis MJ; Sheehy N; Salemi M; VanDamme AM; Hall WW
    Virology; 2002 Mar; 295(1):182-9. PubMed ID: 12033776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of human T lymphotropic virus type 2 Tax proteins.
    Sheehy N; Lillis L; Watters K; Lewis M; Gautier V; Hall W
    Retrovirology; 2006 Mar; 3():20. PubMed ID: 16551350
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.